Cholesterol Lowering and Residual Risk in Diabetes, Type 1 — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(4 sites)
United States
New York VA Hospital, New York, New York NYC Health + Hospitals/Bellevue, New York, New York NYU Langone Health, New York, New York Mount Sinai School of Medicine, New York, New York Last updated December 2025